Back to News
Market Impact: 0.35

Leidos Holdings (LDOS) Valuation Check After OpenAI Partnership And NorthStar 2030 AI Push

LDOS
Artificial IntelligenceTechnology & InnovationInfrastructure & DefenseFiscal Policy & BudgetCompany FundamentalsCapital Returns (Dividends / Buybacks)Insider TransactionsM&A & Restructuring
Leidos Holdings (LDOS) Valuation Check After OpenAI Partnership And NorthStar 2030 AI Push

Leidos announced a partnership with OpenAI to integrate generative and agentic AI into federal workflows as part of its NorthStar 2030 strategy, positioning the company to capture multi-year U.S. federal funding tied to national security and infrastructure programs. Shares trade at $191.23 with a 30‑day return of 2.89%, a 1‑year total shareholder return of 32.69% and multi‑year TSR above 100%; the most followed valuation narrative pegs fair value at $219 (cited as ~12.7% undervalued) while the article also references an indicated intrinsic discount of roughly 34%. Key upside drivers are sustained federal budgets (e.g., One Big Beautiful Bill, FAA modernization), while risks include VA contract uncertainty, acquisition integration challenges and recent insider selling.

Analysis

Market structure: The LDOS–OpenAI tie makes Leidos (LDOS) a direct beneficiary of sticky, higher‑margin AI services for federal programs; expect incumbents with cloud/ML capabilities (LDOS, LMT, NOC, RTX, SAIC) to capture disproportionate share of modernization budgets over the next 3–5 years. Pricing power will rise where contractors can deliver mission‑critical autonomy/agentic solutions, but supply‑side pressure for AI engineers will lift SG&A by mid‑teens percent in the near term unless productivity gains offset it. Fiscal tailwinds (One Big Beautiful Bill) suggest multi‑year demand; near‑term share moves will be influenced more by award cadence than macro growth. Risk assessment: Key tail risks are DoD/federal contract cancellations, emergent export/regulatory controls on generative AI, and dependency on OpenAI’s enterprise pricing/SLAs — each could shave 10–30% off forward EBITDA if realized. Immediate (days–weeks): insider selling may create headline volatility; short term (1–3 quarters): need to see contract wins and margin trajectory; long term (3–5 years): delivery and integration (NorthStar 2030) execution is binary for valuation. Hidden dependency: Leidos’ upside requires OpenAI uptime/pricing stability and favorable appropriations timing. Trade implications: Take a tactical, size‑aware approach: opportunistic long exposure to LDOS (2–3% portfolio) funded by reducing legacy IT exposure (e.g., DXC) — target price $219 in 12 months, stop‑loss 15% or reassess on miss of two successive quarters of order momentum. Use options to lower cost: buy a 12‑month LDOS call spread (buy ATM, sell ~25% OTM) sized 0.5–1% notional to capture re‑rating; add exposure to prime defense names (LMT, NOC) if FY budget passes. Contrarian angles: Consensus underestimates contract execution risk and OpenAI dependency — the market may be underpricing a regulation or SLA shock. Conversely, the market may also be underestimating recurring revenue upside if agentic AI converts project work into platform subscriptions; if Leidos converts 10–15% of revenue to recurring SaaS‑like streams by 2028, EPS could be 20–30% higher than current street forecasts. Watch for early large contract awards (next 90 days) and any OpenAI enterprise terms change as decisive inflection points.